Skip to content

Experimental vaccine for common cancer shows potential in clinical trial

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care. 

Read More

Back To Top